Notify me when Bvf Partners L P/Il files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| MLTX | MoonLake Immunotherapeutics | Class A ordinary share, par value $0.0001 per share | 27.7% | $142M | 19.8M | BVF PARTNERS L P/IL | Nov 6, 2025 | ||
| RPTX | Repare Therapeutics Inc. | Common Shares, no par value | 24% | $18.5M | 10.3M | BVF PARTNERS L P/IL | Nov 20, 2025 | ||
| IVA | Inventiva S.A. | Ordinary Shares, nominal value (euro)0.01 per share | 4.99% | $39.7M | $4.25M | 9.57M | +12% | BVF PARTNERS L P/IL | Nov 17, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|